Symcel announced that Nore from J&J will present ongoing work validating the sterility testing platform at the PDA microbiology conference.

All life is metabolically active. It produces heat – we measure it. Symcel provides solutions for cell and microbial research and testing that enable versatile, rapid, sensitive, and automated detection, even in complex samples. Based on isothermal microcalorimetry technology, the systems provide growth-based, label-free, and non-destructive testing of microbes and how cells respond to treatments. High-sensitivity metabolic detection accelerates testing and can deliver results long before visible growth or conventional readouts become available. Applications include: • Rapid sterility testing of pharmaceuticals and cell and gene therapies • Rapid microbial testing of consumer goods and industrial formulations • Biofilm analysis using in situ models for infection, antimicrobial, and materials studies • Clinical microbiology research, including species detection and antimicrobial susceptibility testing • Food microbiology, enabling detection of microbial contaminants in complex food matrices • Environmental and microbiome in situ analysis of interactions in complex systems • Eukaryotic cell research, including metabolic activity studies in cancer, adipose, and embryo models Symcel is headquartered at the Karolinska Institute in Stockholm and collaborates with leading academic institutions, therapy developers, test laboratories, and industry partners worldwide. What’s your challenge? Let’s solve it together. Visit symcel.com to learn more. Follow our page to stay informed about company updates, application insights, case studies, and career opportunities.

Founded 2004